Age Group(in year) |
Male |
Female |
Total |
|||
n |
% |
n |
% |
n |
% |
|
1-10 |
2 |
2.86 |
7 |
10 |
9 |
12.86 |
11-20 |
24 |
34.28 |
8 |
11.43 |
32 |
45.71 |
21-30 |
12 |
17.15 |
4 |
5.71 |
16 |
22.86 |
31-40 |
3 |
4.28 |
1 |
1.43 |
4 |
5.71 |
41-50 |
5 |
7.14 |
2 |
2.86 |
7 |
10 |
51-60 |
0 |
0 |
0 |
0 |
0 |
0 |
Above 60 |
1 |
1.43 |
1 |
1.43 |
2 |
2.86 |
Total |
47 |
67.14 |
23 |
32.86 |
70 |
100 |
Site of origin |
Male |
Female |
Total |
|||
No. |
% |
No. |
% |
No. |
% |
|
Upper limb |
35 |
50 |
15 |
21.43 |
50 |
71.43 |
Face |
4 |
5.71 |
3 |
4.29 |
7 |
10.00 |
Lower limb |
8 |
11.43 |
5 |
7.14 |
13 |
18.57 |
Total |
47 |
67.14 |
23 |
32.86 |
70 |
100 |
Findings |
Patients |
Percentage |
Normal |
60 |
85.71 |
Focal neurological deficit |
8 |
11.43 |
(a) Monoparesis |
7 |
10 |
(b) Hemiparesis |
1 |
1.43 |
Papilloedema |
2 |
2.86 |
Total |
70 |
100 |